Global Wet Age Related Macular Degeneration (AMD) Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2026

  • receipt Report ID : 19986
  • calendar_today Published On: Mar, 2020
  • file_copy Pages: 119
  • list Pharmaceuticals and Healthcare
Buy @ $3480
Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2026. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.

Scope of the Report:
Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets.
The global Wet Age Related Macular Degeneration (AMD) market is valued at xx million USD in 2020 and is expected to reach xx million USD by the end of 2026, growing at a CAGR of xx% between 2020 and 2026.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Wet Age Related Macular Degeneration (AMD).
Europe also play important roles in global market, with market size of xx million USD in 2020 and will be xx million USD in 2026, with a CAGR of xx%.
This report studies the Wet Age Related Macular Degeneration (AMD) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Wet Age Related Macular Degeneration (AMD) market by product type and applications/end industries.

Market Segment by Companies, this report covers
Novartis International (Switzerland)
Bayer (Germany)
Acucela (U.S.)
Neurotech Pharmaceuticals (U.S.)
Ophthotech (U.S.)
GlaxoSmithKline (U.S.)
Alimera Sciences (U.S.)
StemCell (Canada)
F. Hoffmann-La Roche (Switzerland)
Regeneron Pharmaceutical (U.S.)
Allergan (Ireland)
Adverum Biotechnologies (U.S.)
Gilead Sciences (U.S.)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Wet Age-Related Macular Degeneration (Wet AMD)
Dry Age-Related Macular Degeneration (Dry AMD)

Market Segment by Applications, can be divided into
>75 YearsÊ
>60 YearsÊ
>40 Years
Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Wet Age Related Macular Degeneration (AMD) Market Overview
1.1 Product Overview and Scope of Wet Age Related Macular Degeneration (AMD)
1.2 Classification of Wet Age Related Macular Degeneration (AMD) by Types
1.2.1 Global Wet Age Related Macular Degeneration (AMD) Revenue Comparison by Types (2017-2023)
1.2.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Types in 2019
1.2.3 Wet Age-Related Macular Degeneration (Wet AMD)
1.2.4 Dry Age-Related Macular Degeneration (Dry AMD)
1.3 Global Wet Age Related Macular Degeneration (AMD) Market by Application
1.3.1 Global Wet Age Related Macular Degeneration (AMD) Market Size and Market Share Comparison by Applications (2015-2026)
1.3.2 >75 YearsÊ
1.3.3 >60 YearsÊ
1.3.4 >40 Years
1.4 Global Wet Age Related Macular Degeneration (AMD) Market by Regions
1.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Size (Million USD) Comparison by Regions (2015-2026)
1.4.1 North America (USA, Canada and Mexico) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2026)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2026)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2026)
1.4.4 South America (Brazil, Argentina, Colombia) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2026)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2026)
1.5 Global Market Size of Wet Age Related Macular Degeneration (AMD) (2015-2026)
2 Manufacturers Profiles
2.1 Novartis International (Switzerland)
2.1.1 Business Overview
2.1.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer (Germany)
2.2.1 Business Overview
2.2.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Acucela (U.S.)
2.3.1 Business Overview
2.3.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Acucela (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Neurotech Pharmaceuticals (U.S.)
2.4.1 Business Overview
2.4.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Neurotech Pharmaceuticals (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ophthotech (U.S.)
2.5.1 Business Overview
2.5.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ophthotech (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline (U.S.)
2.6.1 Business Overview
2.6.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Alimera Sciences (U.S.)
2.7.1 Business Overview
2.7.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alimera Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.8 StemCell (Canada)
2.8.1 Business Overview
2.8.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche (Switzerland)
2.9.1 Business Overview
2.9.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Regeneron Pharmaceutical (U.S.)
2.10.1 Business Overview
2.10.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Regeneron Pharmaceutical (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Allergan (Ireland)
2.11.1 Business Overview
2.11.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Adverum Biotechnologies (U.S.)
2.12.1 Business Overview
2.12.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Adverum Biotechnologies (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.13 Gilead Sciences (U.S.)
2.13.1 Business Overview
2.13.2 Wet Age Related Macular Degeneration (AMD) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Gilead Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
3 Global Wet Age Related Macular Degeneration (AMD) Market Competition, by Players
3.1 Global Wet Age Related Macular Degeneration (AMD) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Wet Age Related Macular Degeneration (AMD) Players Market Share
3.2.2 Top 10 Wet Age Related Macular Degeneration (AMD) Players Market Share
3.3 Market Competition Trend
4 Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions
4.1 Global Wet Age Related Macular Degeneration (AMD) Revenue and Market Share by Regions
4.2 North America Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.3 Europe Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.5 South America Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.6 Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5 North America Wet Age Related Macular Degeneration (AMD) Revenue by Countries
5.1 North America Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
5.2 USA Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5.3 Canada Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5.4 Mexico Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6 Europe Wet Age Related Macular Degeneration (AMD) Revenue by Countries
6.1 Europe Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
6.2 Germany Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.3 UK Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.4 France Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.5 Russia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.6 Italy Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue by Countries
7.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
7.2 China Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.3 Japan Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.4 Korea Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.5 India Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
8 South America Wet Age Related Macular Degeneration (AMD) Revenue by Countries
8.1 South America Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
8.2 Brazil Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
8.3 Argentina Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
8.4 Colombia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9 Middle East and Africa Revenue Wet Age Related Macular Degeneration (AMD) by Countries
9.1 Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.3 UAE Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.4 Egypt Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.5 Nigeria Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.6 South Africa Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
10 Global Wet Age Related Macular Degeneration (AMD) Market Segment by Type
10.1 Global Wet Age Related Macular Degeneration (AMD) Revenue and Market Share by Type (2015-2020)
10.2 Global Wet Age Related Macular Degeneration (AMD) Market Forecast by Type (2018-2023)
10.3 Wet Age-Related Macular Degeneration (Wet AMD) Revenue Growth Rate (2015-2026)
10.4 Dry Age-Related Macular Degeneration (Dry AMD) Revenue Growth Rate (2015-2026)
11 Global Wet Age Related Macular Degeneration (AMD) Market Segment by Application
11.1 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2015-2020)
11.2 Wet Age Related Macular Degeneration (AMD) Market Forecast by Application (2018-2023)
11.3 >75 YearsÊ Revenue Growth (2015-2020)
11.4 >60 YearsÊ Revenue Growth (2015-2020)
11.5 >40 Years Revenue Growth (2015-2020)
12 Global Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2018-2023)
12.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2018-2023)
12.2 Global Wet Age Related Macular Degeneration (AMD) Market Forecast by Regions (2018-2023)
12.3 North America Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
12.4 Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
12.6 South America Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Wet Age Related Macular Degeneration (AMD) Picture
Table Product Specifications of Wet Age Related Macular Degeneration (AMD)
Table Global Wet Age Related Macular Degeneration (AMD) and Revenue (Million USD) Market Split by Product Type
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Types in 2019
Figure Wet Age-Related Macular Degeneration (Wet AMD) Picture
Figure Dry Age-Related Macular Degeneration (Dry AMD) Picture
Table Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Application (2015-2026)
Figure Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Applications in 2019
Figure >75 YearsÊ Picture
Figure >60 YearsÊ Picture
Figure >40 Years Picture
Table Global Market Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) Comparison by Regions 2015-2026
Figure North America Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2026)
Figure Europe Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2026)
Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2026)
Figure South America Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2026)
Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2026)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2026)
Table Novartis International (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Bayer (Germany) Basic Information, Manufacturing Base and Competitors
Table Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Acucela (U.S.) Basic Information, Manufacturing Base and Competitors
Table Acucela (U.S.) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Acucela (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Neurotech Pharmaceuticals (U.S.) Basic Information, Manufacturing Base and Competitors
Table Neurotech Pharmaceuticals (U.S.) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Neurotech Pharmaceuticals (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Ophthotech (U.S.) Basic Information, Manufacturing Base and Competitors
Table Ophthotech (U.S.) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Ophthotech (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table GlaxoSmithKline (U.S.) Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline (U.S.) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table GlaxoSmithKline (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Alimera Sciences (U.S.) Basic Information, Manufacturing Base and Competitors
Table Alimera Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Alimera Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table StemCell (Canada) Basic Information, Manufacturing Base and Competitors
Table StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table F. Hoffmann-La Roche (Switzerland) Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Regeneron Pharmaceutical (U.S.) Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceutical (U.S.) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Regeneron Pharmaceutical (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Allergan (Ireland) Basic Information, Manufacturing Base and Competitors
Table Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Adverum Biotechnologies (U.S.) Basic Information, Manufacturing Base and Competitors
Table Adverum Biotechnologies (U.S.) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Adverum Biotechnologies (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Gilead Sciences (U.S.) Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Type and Applications
Table Gilead Sciences (U.S.) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Players (2015-2020)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Players (2015-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Players in 2019
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Players in 2019
Figure Global Top 5 Players Wet Age Related Macular Degeneration (AMD) Revenue Market Share in 2019
Figure Global Top 10 Players Wet Age Related Macular Degeneration (AMD) Revenue Market Share in 2019
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Regions (2015-2020)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2015-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2015-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Regions in 2019
Figure North America Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Europe Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure South America Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Table North America Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
Table North America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure North America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure North America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure USA Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Canada Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Mexico Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Table Europe Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Figure Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure Germany Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure UK Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure France Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Russia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Italy Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure China Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Japan Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Korea Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure India Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Table South America Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
Table South America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure South America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure South America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure Brazil Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Argentina Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Colombia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Table Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure Saudi Arabia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure UAE Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Egypt Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure Nigeria Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure South Africa Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Type (2015-2020)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Type (2015-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Type (2015-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Type in 2019
Table Global Wet Age Related Macular Degeneration (AMD) Revenue Forecast by Type (2018-2023)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Share Forecast by Type (2018-2023)
Figure Global Wet Age-Related Macular Degeneration (Wet AMD) Revenue Growth Rate (2015-2020)
Figure Global Dry Age-Related Macular Degeneration (Dry AMD) Revenue Growth Rate (2015-2020)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue by Application (2015-2020)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Application (2015-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Application (2015-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Application in 2019
Table Global Wet Age Related Macular Degeneration (AMD) Revenue Forecast by Application (2018-2023)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Share Forecast by Application (2018-2023)
Figure Global >75 YearsÊ Revenue Growth Rate (2015-2020)
Figure Global >60 YearsÊ Revenue Growth Rate (2015-2020)
Figure Global >40 Years Revenue Growth Rate (2015-2020)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
Figure Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
Figure South America Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2018-2023)